跳至主要内容
临床试验/NCT02032329
NCT02032329Unknown1 期

FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device

customKYnetics2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
15
试验地点
2
主要终点
Change from baseline in "6-minute Walk Test (6MWT) for Distance" at 12 weeks

研究概览

简要总结

The purpose of this study is to assess efficacy of a pre-commercial device capable of activating both the ankle plantarflexor and dorsiflexor muscles using electrical stimulating during treadmill-based gait training for stroke patients.

详细描述

Difficulty with walking is one of the most common effects of stroke. Even after rehabilitation, a majority of stroke survivors have decreased speed, endurance, confidence, and quality of walking. Walking deficits can cause risks of falls, slow walking speed, increased effort of walking, and difficulties with activities of daily living. Restoration of walking ability can improve quality of life, and is perceived as a major goal of rehabilitation by stroke survivors. There has therefore been renewed interest in research toward developing novel gait rehabilitation treatments and improving existing treatments. FastFES is one such intervention, which improves walking post-stroke using a combination of fast treadmill training and functional electrical stimulation (FES).

Ongoing research at the University of Delaware (R01NR010786) shows that a 12-week FastFES gait rehabilitation program improves walking function, activity, and community participation in stroke survivors.

In order to facilitate implementation of the FastFES gait rehabilitation program in the clinical setting, there is a need to transition from the currently used stimulation system to a more portable stimulation system. The Study Device under evaluation is a pre-commercial prototype (developed by customKYnetics, Inc.) of a clinically viable portable electrical stimulation system that can deliver FES during gait using similar timing and parameters as are being used during FastFES gait rehabilitation training in the ongoing research.

The main goal of the efficacy study is to demonstrate clinical efficacy of the customKYnetics FastFES prototype system for improving the gait of individuals with paresis secondary to stroke. Fifteen (15) post-stroke subjects who meet the inclusion/exclusion criteria will be recruited for participation in this prospective, non-randomized, non-blinded cohort interventional study.

Training (intervention sessions) will be conducted 2-3 times per week for approximately 12 weeks for a total of 36 total sessions. Functional Electrical Stimulation (FES) to the ankle plantarflexor and dorsiflexor muscle groups will be delivered during the gait cycle using a variable frequency train (VFT) stimulation pattern. Stimulation will be coordinated to the gait cycle using data from a shoe-worn inertial sensor and proprietary real-time signal processing algorithm. Stimulation will be turned on and off in 1-minute increments during the training bouts to promote motor learning. The treadmill will be set to the patient's fastest comfortable walking speed. Each intervention session will conclude with a single overground walking session without FES.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21-80
  • Chronic stroke involving cerebral cortical regions (>6 months post stroke).
  • First (single) lesion
  • Ambulatory but with residual gait deficit, including those who use a cane or walker and/or demonstrate asymmetry during gait
  • Able to walk for 6 minutes at their self-selected speed with no orthotic support.
  • Passive ankle dorsiflexion range of motion to neutral degrees with the knee extended (i.e., able to achieve an angle of 90 degrees between the shank and the foot)
  • Passive hip extension of >10 degrees
  • Resting heart rate between 40-100 beats per minute
  • Resting blood pressure between the range of 90/60 to 170/90

排除标准

  • Evidence of moderate to severe chronic white matter disease on MRI
  • Evidence of cerebellar stroke on MRI
  • History of lower extremity joint replacement due to arthritis •Score of >1 on question 1b and >0 on question 1c on the NIH Stroke Scale
  • Inability to communicate with investigators
  • Neglect and hemianopia
  • Unexplained dizziness in the last 6 months

结局指标

主要结局

Change from baseline in "6-minute Walk Test (6MWT) for Distance" at 12 weeks

时间窗: weeks 0 and 12

Distance (meters) walked during the 6-minute Walk Test, a standard clinical assessment of gait will be assessed at 0 and 12 weeks. Test will be performed overground without FES. Change from baseline at 12 weeks will be computed.

次要结局

未报告次要终点

研究者

发起方
customKYnetics
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验